All In Biotech

Free tool

FAERS Monitor: Liletta

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 206229 or its brand name (Liletta, Levonorgestrel). Reports on generic versions are filed under their own applications.

Reports

14,329

Serious

3,453

24% of reports

Hospitalization

731

Death reported

60

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • device expulsion5,536
  • procedural pain1,859
  • device dislocation1,163
  • drug ineffective626
  • off label use546
  • uterine perforation543
  • uterine spasm392
  • nausea295
  • pain278
  • headache230
  • dizziness200
  • abdominal pain199
  • vaginal haemorrhage198
  • uterine haemorrhage193
  • embedded device184

Reports by year received

View as table
YearReports
200439
200539
200637
200727
200822
200945
201064
201193
2012101
201345
201433
2015116
2016657
20171,032
2018476
20191,199
20201,648
20211,420
20221,672
20232,125
20241,282
20251,238
2026919

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,039,830 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
uterine spasmSignal392400.0358.2122,310
device expulsionSignal5,536136.9133.9685,100
procedural painSignal1,859105.4100.8179,443
uterine perforationSignal543100.592.350,006
uterine haemorrhageSignal19369.660.312,395
device dislocationSignal1,16340.338.143,449
embedded deviceSignal18427.824.04,635
vaginal haemorrhageSignal1986.75.9956
abdominal pain1991.31.110
off label use5460.90.84
drug ineffective6260.70.688
pain2780.70.648
dizziness2000.60.559
nausea2950.50.5115
headache2300.50.593

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.